Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OBSERVATIONAL STUDY EVALUATING THE EFFICACY OF TARGETED TREATMENTS FOLLOWING TYROSINE KINASE INHIBITORS IN METASTATIC RENAL CELL CARCINOMA PATIENTS AND EFFECTS ON QUALITY OF LIFE: A NATIONAL, MULTICENTER STUDY

NCT02315755 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02315755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02315755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OBSERVATIONAL STUDY EVALUATING THE EFFICACY OF TARGETED TREATMENTS FOLLOWING TYROSINE KINASE INHIBITORS IN METASTATIC RENAL CELL CARCINOMA PATIENTS AND EFFECTS ON QUALITY OF LIFE: A NATIONAL, MULTICENTER STUDY
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
May 11, 2015
Completion date
November 20, 2017
Enrollment
102 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

renal cell carcinoma